|
1. Bouvier, N. M.; Palese, P. The biology of influenza viruses. Vaccine 2008, 26, D49–D53. 2. Taubenberger, J. K.; Morens, D. M. The pathology of influenza virus infections. Annu. Rev. pathol. 2008, 3, 499–522. 3. Petrova, V. N.; Russell, C. A. The evolution of seasonal influenza viruses. Nat. Rev. Microbiol. 2017, 16, 47. 4. Muramoto, Y.; Noda, T.; Kawakami, E.; Akkina, R.; Kawaoka, Y. Identification of novel influenza A virus proteins translated from PA mRNA. J. Virol. 2013, 87, 2455. 5. Horimoto, T.; Kawaoka, Y. Influenza: lessons from past pandemics, warnings from current incidents. Nat. Rev. Microbiol. 2005, 3, 591−600. 6. Ait-Aissa, A.; Derrar, F.; Hannoun, D.; Gradi, E. A.; Scaravelli, D.; Bouslama, Z. Surveillance for antiviral resistance among influenza viruses circulating in Algeria during five consecutive influenza seasons (2009-2014). J. Med. Virol. 2018, 90, 844−853. 7. Krammer, F.; Smith, G. J. D.; Fouchier, R. A. M.; Peiris, M.; Kedzierska, K.; Doherty, P. C.; Palese, P.; Shaw, M. L.; Treanor, J.; Webster, R. G.; García-Sastre, A. Influenza. Nat. Rev. Dis. Primers. 2018, 4, 3. 8. Hurt, A. C. The epidemiology and spread of drug resistant human influenza viruses. Curr. Opin. Virol. 2014, 8, 22−29. 9. Wang, X.; Jia, W.; Zhao, A.; Wang, X. Anti-influenza agents from plants and traditional Chinese medicine. Phytother Res. 2006, 20, 335−341. 10. Watanabe, T.; Kawaoka, Y. Influenza virus-host interactomes as a basis for antiviral drug development. Curr. Opin. Virol. 2015, 14, 71−78. 11. Sheu, T. G.; Deyde, V. M.; Okomo-Adhiambo, M.; Garten, R. J.; Xu, X.; Bright, R. A.; Butler, E. N.; Wallis, T. R.; Klimov, A. I.; Gubareva, L. V. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob. Agents Chemother. 2008, 52, 3284. 12. Hutchinson, E. C.; Fodor, E. Transport of the influenza virus genome from nucleus to nucleus. Viruses 2013, 5, 2424−2446. 13. Portela, A.; Digard, P. The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication. J. Gen. Virol. 2002, 8, 723−734. 14. Ye, Q.; Krug, R. M.; Tao, Y. J. The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA. Nature 2006, 444, 1078−1082. 15. Turrell, L.; Lyall, J. W.; Tiley, L. S.; Fodor, E.; Vreede, F. T. The role and assembly mechanism of nucleoprotein in influenza A virus ribonucleoprotein complexes. Nature Comm. 2013, 4, 1591. 16. Shen, Y.-F.; Chen, Y.-H.; Chu, S.-Y.; Lin, M.-I.; Hsu, H.-T.; Wu, P.-Y.; Wu, C.-J.; Liu, H.-W.; Lin, F.-Y.; Lin, G.; Hsu, P.-H.; Yang, A.-S.; Cheng, Y.-S. E.; Wu, Y.-T.; Wong, C.-H.; Tsai, M.-D. E339…R416 salt bridge of nucleoprotein as a feasible target for influenza virus inhibitors. Proc. Natl. Acad. Sci. 2011, 108, 16515−16520. 17. Kao, R. Y.; Yang, D.; Lau, L.-S.; Tsui, W. H. W.; Hu, L.; Dai, J.; Chan, M.-P.; Chan, C.-M.; Wang, P.; Zheng, B.-J.; Sun, J.; Huang, J.-D.; Madar, J.; Chen, G.; Chen, H.; Guan, Y.; Yuen, K.-Y. Identification of influenza A nucleoprotein as an antiviral target. Nat. Biotechnol. 2010, 28, 600. 18. Gerritz, S. W.; Cianci, C.; Kim, S.; Pearce, B. C.; Deminie, C.; Discotto, L.; McAuliffe, B.; Minassian, B. F.; Shi, S.; Zhu, S.; Zhai, W.; Pendri, A.; Li, G.; Poss, M. A.; Edavettal, S.; McDonnell, P. A.; Lewis, H. A.; Maskos, K.; Mörtl, M.; Kiefersauer, R.; Steinbacher, S.; Baldwin, E. T.; Metzler, W.; Bryson, J.; Healy, M. D.; Philip, T.; Zoeckler, M.; Schartman, R.; Sinz, M.; Leyva-Grado, V. H.; Hoffmann, H.-H.; Langley, D. R.; Meanwell, N. A.; Krystal, M. Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers. Proc. Natl. Acad. Sci. U.S.A. 2011, 10, 15366−15371. 19. Pang, B.; Cheung, N. N.; Zhang, W.; Dai, J.; Kao, R. Y.; Zhang, H.; Hao, Q. Structural characterization of H1N1 nucleoprotein−nucleozin binding sites. Sci. Rep. 2016, 6. 20. Shu, L. L.; Bean, W. J.; Webster, R. G. Analysis of the evolution and variation of the human influenza A virus nucleoprotein gene from 1933 to 1990. J. Virol.1993, 67, 2723−2729. 21. Wang, S.; Tian, Y.; Wang, M.; Wang, M.; Sun, G.-B.; Sun, X.-B. Advanced activity-based protein profiling application strategies for drug development. Front. Pharmacol. 2018, 9. 22. Sumranjit, J.; Chung, S. J. Recent advances in target characterization and identification by photoaffinity probes. Molecules 2013, 18, 10425−10451. 23. Smith, E.; Collins, I. Photoaffinity labeling in target- and binding-site identification. Future Med. Chem. 2015, 7, 159−183. 24. Tanaka, Y.; Bond, M. R.; Kohler, J. J. Photocrosslinkers illuminate interactions in living cells. Mol. Biosyst. 2008, 4, 473−480. 25. Sadaghiani, A. M.; Verhelst, S. H. L.; Bogyo, M. Tagging and detection strategies for activity-based proteomics. Curr. Opin. Chem. Biol. 2007, 11, 20−28. 26. Lapinsky, D. J. Tandem photoaffinity labeling–bioorthogonal conjugation in medicinal chemistry. Bioorg. Med. Chem. 2012, 20, 6237−6247. 27. Jewett, J. C.; Bertozzi, C. R. Cu-free click cycloaddition reactions in chemical biology. Chem. Soc. Rev. 2010, 39, 1272−1279. 28. Thiede, B.; Höhenwarter, W.; Krah, A.; Mattow, J.; Schmid, M.; Schmidt, F.; Jungblut, P. R. Peptide mass fingerprinting. Methods 2005, 35, 237−247. 29. Baldwin, M. A. Protein Identification by Mass Spectrometry. Mol. Cell. Proteom. 2004, 3, 1. 30. Cottrell, J. S. Protein identification using MS/MS data. J. Proteom. 2011, 74, 1842−1851. 31. Eng, J. K.; McCormack, A. L.; Yates, J. R. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrom. 1994, 5, 976−989. 32. Corderoa, F. M.; Bonanno, P.; Chioccioli, M.; Gratteri, P.; Robina, I.; Vargas, A. J. M.; Brandi, Alberto. Diversity-oriented syntheses of 7-substituted lentiginosines. Tetrahedron 2011, 67, 9555−9564. 33. Nainar, S.; Kubota, M.; McNitt, C.; Tran, C.; Popik, V. V.; Spitale, R. C. Temporal labeling of nascent RNA using photoclick chemistry in live cells. J. Am. Chem. Soc. 2017, 139, 8090−8093. 34. Evan, P. K.; Rudolph, A. A. Photolysis of alkyl azides. Evidence for a nonnitrene mechanism. J. Am. Chem. Soc. 1980, 102, 735-740. 35. Saxena, A. K.; Pandey, S. K.; Seth, P.; Singh, M. P.; Dikshit, M.; Carpy, A. Synthesis and QSAR studies in 2-(N-aryl-N-aroyl)amino-4,5-dihydrothiazole derivatives as potential antithrombotic agents. Bioorg. Med. Chem. 2001, 9, 2025–2034. 36. Hajipour, A. R.; Mohammadsaleh, F. Preparation of Aryl Azides from Aromatic Amines in N-Methyl-2-Pyrrolidonium Bisulfate. Org. Prep. Proced. Int. 2011, 43, 451–455.
|